The Pandemic of COVID-19, caused by SARS-CoV-2, is a new disease, nothing was known about it including pathogenesis, course of the disease, treatment, complications, or even its sequels. Treatment was mostly symptomatic with daily changing protocols. Many lost their lives either due to the infection or due to complications or post-recovery sequels like mucormycosis or Multisystem Inflammatory Syndrome (MIS). MIS was a related post-recovery sequel, which was not exactly understood in the very early stages. Later when it was confirmed as a complication of COVID-19, treatment protocols were framed, mostly symptomatic. The recovery was painful with varying morbidity and recovery rates. Modern medicine did succeed in framing the diagnostic guidelines but failed in providing a foolproof inclusive treatment protocol. The present case series focuses on the encouraging results obtained through Ayurveda in managing MIS, using cost-effective and commonly used anti-inflammatory medicines which proved to be effective in reducing the symptoms and also the biochemical inflammatory markers.
Key words: Multisystem Inflammatory Syndrome (MIS), Covid-19, Sadangodaka, Dasamula Kwatha, Rasnapancaka Kwatha
|
